(Upcoming Event) Seminar “Solution for Global Health Issues -Public and Private Partnership-“
date : 10/11/2013
*Application form is the bottom.
In recent years, there has been rapid economic growth in some developing countries which is seen as a new market opportunity for businesses, however, these countries are disadvantaged by their limited access to medical resources. In particular they are significantly handicapped by the three major infectious diseases i.e. HIV/AIDS, Tuberculosis, Malaria, and NTD (Neglected Tropical Diseases).
As public funding is limited, an innovative business model called “Public-Private-Partnership”(PPP) plays an important role in solving global health issues in developing countries. PPP is a government service or private business venture which is funded and operated through a partnership of government and one or more private sector companies.
In the first session of the current sequential seminars, we would like to hold discussion about why PPP has drawn great attention especially in the global health field. By introducing examples of PPP by The Global Health Innovative Technology Fund (GHIT Fund,) which aims to solve global health issues, we would also like to discuss how government and private sector companies can cooperate and maximize the partnership. The GHIT Fund is a non-profit organization aimed at promoting the discovery and development of new health technologies including drugs, vaccines and diagnostics for infectious diseases prevalent in developing counties.The first partnership of its kind in Japan, the GHIT Fund is a PPP established by the Government of Japan, a consortium of Japanese pharmaceutical companies and the Bill & Melinda Gates Foundation in 2012. Through the session, we would like to discuss and explore sustainable ways of contributing to global health solutions with speakers and audience participation.
We welcome business persons, researchers who aim to contribute to medical drug development for developing countries, people from NGO, NPO public administrations, international organizations, students and so on.
*Language: Japanese
■Date and Time
Oct 23, 2013 19:00-21:00
■Venue
ARK HILLS Club
37F East Wing, ARK Mori Building,
1-12-32 Akasaka, Minato-ku, Tokyo
■Theme
“Global Health and Public-Private Partnership”
■Speaker
–Kiyoshi Kurokawa
Professor, National Graduate Institute for Policy Studies / Chairman, Health and Global Policy Institute / Chair of the Board & Representative Director, Global Health Innovative Technology Fund
–Kei Katsuno
Director of Strategy, Global Health Innovative Technology Fund
■Fee
1,500 Yen (Student 1,000yen(Please show your school identification card.))
■Application Procedure
Please complete the online procedure on the Health and Global Policy Institute website by noon on Monday, Oct 21th, 2013. When the seats are fully booked, we may stop accepting applications.
■Organizer
Health and Global Policy Institute
Since its establishment in 2004, the Health and Global Policy Institute (HGPI) has been working to help interested citizens shape health policies by generating policy options and bringing stakeholders together as a nonpartisan think tank. HGPI’s mission is to improve civic and individual well-being and to foster as sustainable healthy community by shaping ideas and values, reaching out to global needs, and catalyzing society for impact. HGPI commits to activities that bring together relevant players in different fields to provide innovative and practical solutions and help interested citizens understand choices and benefits in a global, long-term perspective. HGPI promotes a Global Citizen Nation by building a society for people with various backgrounds and different values. It aims to achieve a sustainable, healthy, and more prosperous world.
Global Health Innovative Technology Fund
The Global Health Innovative Technology Fund (GHIT Fund) is Japan’s first public-private partnership to advance the development of new health technologies for the developing world.
The first product development fund of its kind in Japan, the GHIT Fund was created by the Japanese Government, Japan’s leading pharmaceutical companies, and the Bill & Melinda Gates Foundation.
The GHIT Fund is bringing Japanese leadership in health and technology innovation from its public and private sectors to the global fight against infectious diseases. The goals is to facilitate and fund
global health R&D partnerships that can generate new drugs, vaccines and diagnostics and other tools for fighting neglected diseases prevalent in developing world.
■In Cooperation with
MORI HOSPITALITY CORPORATION
■Secretariat
Health and Global Policy Institute
Tel: 03-5511-8521
Email: info@hgpi.org
Normal 0 0 2 false false false EN-US JA X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:標準の表; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:””; mso-padding-alt:0mm 5.4pt 0mm 5.4pt; mso-para-margin:0mm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.5pt; mso-bidi-font-size:11.0pt; font-family:”Arial”,”sans-serif”; mso-ascii-font-family:Arial; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Arial; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:”Times New Roman”; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt;}
In recent years, there has been rapid economic growth in some developing countries which is seen as a new market opportunity for businesses, however, these countries are disadvantaged by their limited access to medical resources. In particular they are significantly handicapped by the three major infectious diseases i.e. HIV/AIDS, Tuberculosis, Malaria, and NTD (Neglected Tropical Diseases).
As public funding is limited, an innovative business model called “Public-Private-Partnership”(PPP) plays an important role in solving global health issues in developing countries. PPP is a government service or private business venture which is funded and operated through a partnership of government and one or more private sector companies.
In the first session of the current sequential seminars, we would like to hold discussion about why PPP has drawn great attention especially in the global health field. By introducing examples of PPP by The Global Health Innovative Technology Fund (GHIT Fund,) which aims to solve global health issues, we would also like to discuss how government and private sector companies can cooperate and maximize the partnership. The GHIT Fund is a non-profit organization aimed at promoting the discovery and development of new health technologies including drugs, vaccines and diagnostics for infectious diseases prevalent in developing counties.The first partnership of its kind in Japan, the GHIT Fund is a PPP established by the Government of Japan, a consortium of Japanese pharmaceutical companies and the Bill & Melinda Gates Foundation in 2012. Through the session, we would like to discuss and explore sustainable ways of contributing to global health solutions with speakers and audience participation.
We welcome business persons, researchers who aim to contribute to medical drug development for developing countries, people from NGO, NPO public administrations, international organizations, students and so on.
*Language: Japanese
■Date and Time
Oct 23, 2013 19:00-21:00
■Venue
ARK HILLS Club
37F East Wing, ARK Mori Building,
1-12-32 Akasaka, Minato-ku, Tokyo
■Theme
“Global Health and Public-Private Partnership”
■Speaker
–Kiyoshi Kurokawa
Professor, National Graduate Institute for Policy Studies / Chairman, Health and Global Policy Institute / Chair of the Board & Representative Director, Global Health Innovative Technology Fund
–Kei Katsuno
Director of Strategy, Global Health Innovative Technology Fund
■Fee
1,500 Yen (Student 1,000yen(Please show your school identification card.))
■Application Procedure
Please complete the online procedure on the Health and Global Policy Institute website by noon on Monday, Oct 21th, 2013. When the seats are fully booked, we may stop accepting applications.
■Organizer
Health and Global Policy Institute
Since its establishment in 2004, the Health and Global Policy Institute (HGPI) has been working to help interested citizens shape health policies by generating policy options and bringing stakeholders together as a nonpartisan think tank. HGPI’s mission is to improve civic and individual well-being and to foster as sustainable healthy community by shaping ideas and values, reaching out to global needs, and catalyzing society for impact. HGPI commits to activities that bring together relevant players in different fields to provide innovative and practical solutions and help interested citizens understand choices and benefits in a global, long-term perspective. HGPI promotes a Global Citizen Nation by building a society for people with various backgrounds and different values. It aims to achieve a sustainable, healthy, and more prosperous world.
Global Health Innovative Technology Fund
The Global Health Innovative Technology Fund (GHIT Fund) is Japan’s first public-private partnership to advance the development of new health technologies for the developing world.
The first product development fund of its kind in Japan, the GHIT Fund was created by the Japanese Government, Japan’s leading pharmaceutical companies, and the Bill & Melinda Gates Foundation.
The GHIT Fund is bringing Japanese leadership in health and technology innovation from its public and private sectors to the global fight against infectious diseases. The goals is to facilitate and fund
global health R&D partnerships that can generate new drugs, vaccines and diagnostics and other tools for fighting neglected diseases prevalent in developing world.
■In Cooperation with
MORI HOSPITALITY CORPORATION
■Secretariat
Health and Global Policy Institute
Tel: 03-5511-8521
Email: info@hgpi.org
Normal 0 0 2 false false false EN-US JA X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:標準の表; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:””; mso-padding-alt:0mm 5.4pt 0mm 5.4pt; mso-para-margin:0mm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.5pt; mso-bidi-font-size:11.0pt; font-family:”Arial”,”sans-serif”; mso-ascii-font-family:Arial; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Arial; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:”Times New Roman”; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt;}
Registration deadline: 2013-10-22
Exhibition date：2013-10-23
